Treatment Recommendations for Osteosarcoma and Adult Soft Tissue Sarcomas
- 1 January 1994
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 47 (1) , 82-92
- https://doi.org/10.2165/00003495-199447010-00006
Abstract
During the past 20 years, dramatic improvements have been obtained in the treatment of localised osteosarcoma of the extremities, both in the rates of disease-free survival and in quality of life. Twenty years ago 80 to 90% of the patients died, in spite of mutilating surgery, but now about 75% survive and avoid the necessity of amputation. This is due to the introduction of very effective combined treatments, mostly also using preoperative chemotherapy. One of the major issues is that of intensive preoperative chemotherapy, which improves both limb salvage and survival. A multidisciplinary approach is necessary to obtain good results. When the role of adjuvant or neoadjuvant chemotherapy is not accurately defined for soft tissue sarcomas, particular emphasis is given to the staging of the diseases and to the important role of local treatment in the survival of these patients. A combination of radiation therapy and surgery is strongly recommended.Keywords
This publication has 45 references indexed in Scilit:
- Doxorubicin (or epidoxorubicin) combined with ifosfamide in the treatment of adult advanced soft tissue sarcomasAnnals of Oncology, 1992
- Preoperative irradiation for soft tissue sarcomas of the trunk and extremities in adultsInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Chemotherapy-Induced MyelosuppressionNew England Journal of Medicine, 1988
- Treatment of soft tissue sarcomas by preoperative irradiation and conservative surgical resectionInternational Journal of Radiation Oncology*Biology*Physics, 1988
- Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC soft tissue and bone sarcoma groupEuropean Journal of Cancer and Clinical Oncology, 1987
- Long-term evaluation of surgery followed by adjuvant adriamycin in osteogenic sarcomaEuropean Journal of Cancer and Clinical Oncology, 1987
- Adriamycin-methotrexate high dose versus adriamycin-methotrexate moderate dose as adjuvant chemotherapy for osteosarcoma of the extremities: a randomized studyEuropean Journal of Cancer and Clinical Oncology, 1986
- The Effect of Adjuvant Chemotherapy on Relapse-Free Survival in Patients with Osteosarcoma of the ExtremityNew England Journal of Medicine, 1986
- Adjuvant Methotrexate and Citrovorum-Factor Treatment of Osteogenic SarcomaNew England Journal of Medicine, 1974
- Favorable response of metastatic osteogenic sarcoma to pulse high-dose methotrexate with citrovorum rescue and radiation therapyCancer, 1973